Hangzhou Aoyipollen Pharmaceutical

Hangzhou Aoyipollen Pharmaceutical is a specialized pharmaceutical company based in Hangzhou, China, that focuses on the research and production of pollen-based medicinal products. Established in 1994, the company has developed a niche expertise in utilizing bioactive pollen extracts for the treatment of urological conditions. Its primary product line includes treatments for benign prostatic hyperplasia (BPH) and chronic prostatitis, which are marketed under the Aoyi brand. The company operates GMP-certified manufacturing facilities to ensure the high quality and standardization of its natural extracts. Hangzhou Aoyipollen Pharmaceutical is a key player in the integration of traditional natural medicine with modern pharmaceutical standards in the Chinese market. Its research efforts continue to explore the broader therapeutic potential of pollen-derived compounds in men's health and immune modulation.